Indications and uses
temporarily relieves minor sore throat pain sore mouth minor mouth irritation pain associated with canker sores
temporarily relieves minor sore throat pain sore mouth minor mouth irritation pain associated with canker sores
dissolve a lozenge slowly in mouth adults and children 12 years and older take up to 2 lozenges every 2 hours as needed children 6 to under 12 years take up to 1 lozenge every 2 hours; not more than 10 lozenges in 24 hours children under 6 years ask a doctor
Store at room temperature, below 86°F (30°C). Protect contents from humidity.
Drug Facts
Phenol 29 mg
Oral Anesthetic
temporarily relieves
When using this product
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 12 years and older | take up to 2 lozenges every 2 hours as needed |
| children 6 to under 12 years | take up to 1 lozenge every 2 hours; not more than 10 lozenges in 24 hours |
| children under 6 years | ask a doctor |
Store at room temperature, below 86°F (30°C). Protect contents from humidity.
Antifoam Emulsion, Caramel, Eucalyptus Oil, Gum Crystal, Menthol, and Sorbitol.
Call 1-800-344-7239 or visit our website at
www.insightpharma.com
Distributed by: INSIGHT Pharmaceuticals Corp.
Langhorne, PA 19047-1749
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63736-219-18 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-c5a9-621f-e053-dbdaa90a74ad | CĒPASTAT ® ORAL ANESTHETIC WITH PHENOL |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63736-219-18 | CepastatExtra Strength | 18 in 1 BOX | LOZENGE | 18 | 1 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63736-219-18 | EA - Each | 63736-219 | 5124ec95-f64c-4d13-addf-c685b984e706 | 1 | 2018-03-08 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Phenol | ACTIVE INGREDIENT | 339NCG44TV | 1 | |
| Phenol | ACTIVE MOIETY | 339NCG44TV | 1 | |
| Caramel | INACTIVE INGREDIENT | T9D99G2B1R | 1 | |
| Eucalyptus Oil | INACTIVE INGREDIENT | 2R04ONI662 | 1 | |
| Menthol | INACTIVE INGREDIENT | L7T10EIP3A | 1 | |
| Sorbitol | INACTIVE INGREDIENT | 506T60A25R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63736-219 | 63736-219-18 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Phenol | 339NCG44TV | ACTIB |
| Caramel | T9D99G2B1R | IACT |
| Eucalyptus Oil | 2R04ONI662 | IACT |
| Menthol | L7T10EIP3A | IACT |
| Sorbitol | 506T60A25R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Menthol | MENTHOL | L7T10EIP3A | CREAM / TOPICAL | 0.1 %w/w | ||
| Menthol | MENTHOL | L7T10EIP3A | DROPS / NASAL | 40.32 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | GUM, CHEWING / BUCCAL | 5110 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET / ORAL | 337.28 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | TABLET / SUBLINGUAL | 2 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET, FILM COATED / ORAL | 5 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | MOUTHWASH / BUCCAL | 0.15 mg/1ml | ||
| Sorbitol | SORBITOL | 506T60A25R | PASTE / DENTAL | 14.6 %w/w | ||
| Caramel | CARAMEL | T9D99G2B1R | GRANULE, FOR SUSPENSION / ORAL | 2.5 mg/5ml | ||
| Caramel | CARAMEL | T9D99G2B1R | SUSPENSION / ORAL | 111.12 mg/5ml | ||
| Menthol | MENTHOL | L7T10EIP3A | GUM, CHEWING / BUCCAL | 89 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION / INTRASYNOVIAL | 45 %w/v | ||
| Sorbitol | SORBITOL | 506T60A25R | SUSPENSION / ORAL | 45000 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | PASTE, DENTIFRICE / DENTAL | 14 %w/w | ||
| Menthol | MENTHOL | L7T10EIP3A | SOLUTION / DENTAL | NA | ||
| Menthol | MENTHOL | L7T10EIP3A | SOLUTION, CONCENTRATE / ORAL | 0.5 mg/1ml | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION, SOLUTION / SUBCUTANEOUS | 4.7 %w/v | ||
| Menthol | MENTHOL | L7T10EIP3A | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET, COATED / ORAL | 12.96 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET, ORALLY DISINTEGRATING / ORAL | 7 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | OINTMENT / TOPICAL | 10 %w/w | ||
| Caramel | CARAMEL | T9D99G2B1R | LOTION / TOPICAL | NA | ||
| Sorbitol | SORBITOL | 506T60A25R | SYSTEM / TOPICAL | 6300 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | SOLUTION / ORAL | 3 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | CAPSULE / ORAL | 1111 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | CONCENTRATE / ORAL | 0.05 mg/5ml | ||
| Menthol | MENTHOL | L7T10EIP3A | GEL / TOPICAL | 0.1 %w/w | ||
| Menthol | MENTHOL | L7T10EIP3A | TABLET, ORALLY DISINTEGRATING / ORAL | 14 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 1.04 %w/v | ||
| Caramel | CARAMEL | T9D99G2B1R | SOLUTION / RECTAL | NA | ||
| Sorbitol | SORBITOL | 506T60A25R | LOTION / TOPICAL | 10.7 %w/w | ||
| Menthol | MENTHOL | L7T10EIP3A | AEROSOL, METERED / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| Sorbitol | SORBITOL | 506T60A25R | POWDER / ORAL | 36000 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SOLUTION / OPHTHALMIC | 6 mg | ||
| Caramel | CARAMEL | T9D99G2B1R | SYRUP / ORAL | 207 mg/5ml | ||
| Menthol | MENTHOL | L7T10EIP3A | SOAP / TOPICAL | 0.75 %w/w | ||
| Sorbitol | SORBITOL | 506T60A25R | LIQUID / ORAL | 53460 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | LIQUID / TOPICAL | 1 %w/w | ||
| Menthol | MENTHOL | L7T10EIP3A | INHALANT / NASAL | 32 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | JELLY / NASAL | 32.5 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SOLUTION / ORAL | 29268 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET / SUBLINGUAL | 50.5 mg | ||
| Caramel | CARAMEL | T9D99G2B1R | LIQUID / ORAL | 5.3 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET, CHEWABLE / ORAL | 3555 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SOLUTION / NASAL | 25 mg/1ml | ||
| Sorbitol | SORBITOL | 506T60A25R | POWDER, FOR SUSPENSION / ORAL | 12000 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | ELIXIR / ORAL | 833.3 mg | ||
| Caramel | CARAMEL | T9D99G2B1R | SOLUTION / ORAL | 11 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION / INTRALESIONAL | 45 %w/v | ||
| Caramel | CARAMEL | T9D99G2B1R | CAPSULE / ORAL | NA | ||
| Menthol | MENTHOL | L7T10EIP3A | POWDER, FOR SOLUTION / ORAL | NA | ||
| Sorbitol | SORBITOL | 506T60A25R | SOLUTION/ DROPS / OPHTHALMIC | 0.25 %w/v | ||
| Sorbitol | SORBITOL | 506T60A25R | AEROSOL, FOAM / TOPICAL | 4.95 %w/w | ||
| Eucalyptus Oil | EUCALYPTUS OIL | 2R04ONI662 | SYRUP / ORAL | NA | ||
| Menthol | MENTHOL | L7T10EIP3A | CAPSULE / ORAL | 0.87 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SUSPENSION / RECTAL | 46.18 %w/v | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET, EXTENDED RELEASE / ORAL | 428 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION / SUBCUTANEOUS | 4.7 %w/v | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION / INTRA-ARTICULAR | 45 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a33617f8-fc6a-4c06-8f96-fed5b5d6d570 | 1613c687-411e-487d-b672-a3d849d53e5f | 2009-07-09 | Warnings | a33617f8-fc6a-4c06-8f96-fed5b5d6d570 1613c687-411e-487d-b672-a3d849d53e5f |
Adverse event summaries are temporarily unavailable. Other product information remains available.